Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 143K 125K 116K 107K 201K 13.67M 205K 1.37M 537K 6.82M 539K 527K 22.48M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.94M 18.62M 17.09M 32.23M 2.19B 32.79M 220M 85.99M 1.09B 86.2M 84.29M 3.6B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.17% | +3.25% | +23.82% | +5.35% | 212B | ||
| +1.37% | +0.84% | +0.35% | -23.03% | 137B | ||
| +5.43% | +4.18% | -23.09% | +19.43% | 125B | ||
| +3.35% | +5.59% | -55.00% | -5.55% | 69.46B | ||
| +2.83% | +6.65% | +10.58% | +10.71% | 49.56B | ||
| +6.10% | +9.98% | -15.42% | -19.36% | 47.2B | ||
| +1.25% | +1.61% | +22.00% | +12.04% | 39.08B | ||
| -0.25% | +1.51% | +31.94% | +29.30% | 37.05B | ||
| -2.56% | +5.95% | +103.92% | +8.31% | 30.97B | ||
| Average | +1.99% | +3.19% | +11.01% | +4.13% | 83.06B | |
| Weighted average by Cap. | +2.05% | +2.80% | +4.63% | +1.94% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.5M 1.4M 1.29M 2.43M 165M 2.47M 16.55M 6.48M 82.2M 6.5M 6.35M 271M | 1.98M 1.72M 1.6M 1.47M 2.78M 189M 2.83M 18.92M 7.41M 94.01M 7.43M 7.26M 310M |
| Net income | -16.08M -13.97M -13.04M -11.98M -22.58M -1.53B -22.97M -154M -60.24M -764M -60.39M -59.05M -2.52B | -29.31M -25.48M -23.79M -21.84M -41.17M -2.79B -41.89M -280M -110M -1.39B -110M -108M -4.6B |
| Net Debt | 20.53M 17.84M 16.65M 15.29M 28.83M 1.96B 29.33M 196M 76.91M 976M 77.1M 75.39M 3.22B | 22.8M 19.82M 18.5M 16.99M 32.03M 2.17B 32.59M 218M 85.45M 1.08B 85.66M 83.76M 3.58B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















